Quest Pharmatech (TSE:QPT) has released an update.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Quest PharmaTech Inc. has successfully concluded its annual general meeting, resulting in the election of four directors to its Board and the reappointment of its auditors. The company also disclosed the grant of 1.8 million stock options to Directors and Officers, pending regulatory approval. Quest continues to advance in biopharmaceutical development, including a promising theranostic agent for cancer in late preclinical stage.
For further insights into TSE:QPT stock, check out TipRanks’ Stock Analysis page.